LightCycler SeptiFast technology in patients with solid malignancies: clinical utility for rapid etiologic diagnosis of sepsis

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F12%3A00062242" target="_blank" >RIV/00216224:14110/12:00062242 - isvavai.cz</a>

Výsledek na webu

<a href="http://ccforum.com/content/16/1/404" target="_blank" >http://ccforum.com/content/16/1/404</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1186/cc10595" target="_blank" >10.1186/cc10595</a>

Jazyk výsledku

angličtina

Název v původním jazyce

LightCycler SeptiFast technology in patients with solid malignancies: clinical utility for rapid etiologic diagnosis of sepsis

Popis výsledku v původním jazyce

We retrospectively evaluated 54 results of the SeptiFast test from patients with solid malignancy admitted to the ICU between June 2009 and August 2011. Specimens from suspected bloodstream infection were analyzed using LightCycler SeptiFast (Roche Molecular Diagnostics according to the manufacturers instruction and evaluated in comparison with blood culture results obtained from blood sampled no longer than 24 hours before or after sampling for SeptiFast. Blood culturing and identification were performed according to the routine diagnostic procedures. The total number of blood cultures analyzed was 85, and finding a microorganism by either of the two tests was evaluated as positive. Consistently, negative results from SeptiFast and blood culture wereobtained in 21 (39%) cases.

Název v anglickém jazyce

LightCycler SeptiFast technology in patients with solid malignancies: clinical utility for rapid etiologic diagnosis of sepsis

Popis výsledku anglicky

We retrospectively evaluated 54 results of the SeptiFast test from patients with solid malignancy admitted to the ICU between June 2009 and August 2011. Specimens from suspected bloodstream infection were analyzed using LightCycler SeptiFast (Roche Molecular Diagnostics according to the manufacturers instruction and evaluated in comparison with blood culture results obtained from blood sampled no longer than 24 hours before or after sampling for SeptiFast. Blood culturing and identification were performed according to the routine diagnostic procedures. The total number of blood cultures analyzed was 85, and finding a microorganism by either of the two tests was evaluated as positive. Consistently, negative results from SeptiFast and blood culture wereobtained in 21 (39%) cases.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FE - Ostatní obory vnitřního lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Critical Care

ISSN

1466-609X

e-ISSN

—

Svazek periodika

16

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

3

Strana od-do

—

Kód UT WoS článku

000305393400063

EID výsledku v databázi Scopus

—